Which medications are used for stroke prevention in the treatment of cardioembolic transient ischemic attack (TIA)?

Updated: Dec 03, 2018
  • Author: Ashish Nanda, MD; Chief Editor: Andrew K Chang, MD, MS  more...
  • Print

Stroke prevention medication typically recommended for cardioembolic TIA is as follows:

  • For patients with atrial fibrillation after TIA, long-term anticoagulation with warfarin (target international normalized ratio [INR], 2-3); aspirin 325 mg/day for those unable to take oral anticoagulants

  • In acute myocardial infarction (MI) with left ventricular thrombus, oral anticoagulation with warfarin (target INR, 2-3; concurrent aspirin up to 162 mg/day for ischemic coronary artery disease [CAD])

  • In dilated cardiomyopathy, oral anticoagulation with warfarin (target INR, 2-3) or antiplatelet therapy

  • In rheumatic mitral valve disease, oral anticoagulation with warfarin (target INR, 2-3)

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!